The European Medicines Agency (EMA), in partnership with the European Commission (EC) and the Heads of Medicines Agencies ...

In SELVA Phase 3 study, 100% of participants (13/13) aged 6–11 years were rated as “Much Improved” (+2) or “Very Much ...

A new study published in the journal of Neurology revealed that semaglutide may increase the risk of non-arteritic anterior ...

And randomized trial shows safety is on par ...

Tom Steyer ranks among the list of the richest hedge fund managers in the world. Revolution Medicines, Inc. (NASDAQ:RVMD) is Tom Steyer’s largest holding, accounting for 5.26% of the billionaire’s ...

Experts voiced support for the nomination of Erica Schwartz, MD, MPH, JD, a deeply credentialed physician with public health ...

Introduction Serum chloride has been recently recognised as a predictor of short-term mortality in patients hospitalised with ...

Shockwave Centers of America has outlined the science behind shockwave therapy as a non-invasive treatment option for ...

Detailed price information for Akebia Therapeutics (AKBA-Q) from The Globe and Mail including charting and trades.

Cerebral Palsy Guide is drawing attention to the well-documented connection between premature birth and cerebral palsy risk, as new research continues to sharpen the understanding of how gestational a ...

Introduction Congenital malformations (CMs) are the leading cause of infant mortality. Still, the aetiology remains unknown in 70% of cases. The most accepted hypothesis is that hereditary and ...